Results 71 to 80 of about 3,956 (171)

Thyrotropin Receptor Antibody Levels in Patients with Autoimmune Thyroid Disease in Iodine Deficient Areas

open access: yesEndocrinology Research and Practice, 2022
In this study, we investigated Thyrotropin Receptor Antibody (TRab) levels in Hashimoto and Graves' diseases. A total of 189 patients and 25 controls were assessed, retrospectively.
Demet Çorapçıoğlu   +8 more
doaj   +2 more sources

Update on the medical treatment of Graves’ ophthalmopathy

open access: yes, 2009
Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
core  

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy

open access: yes, 2012
Tom McCorquodale,1 Hooshang Lahooti,1 Bamini Gopinath,2 Jack R Wall11Department of Medicine, Nepean Clinical School, the University of Sydney, Penrith, NSW, Australia; 2Centre for Vision Research, the University of Sydney, Westmead Hospital, Westmead ...
Gopinath B   +3 more
core  

The relationship between Graves’ ophthalmopathy and dry eye syndrome

open access: yes, 2014
Jessica H Selter,1 Anisa I Gire,2 Shameema Sikder2 1Johns Hopkins School of Medicine, 2Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA Background: A complex relationship between Graves&rsquo ...
Sikder S, Selter JH, Gire AI
core  

Management of patients with endocrine ophthalmopathy and Graves' disease: results of an endocrinologist and ophthalmologist survey in Russia

open access: yesМедицинский совет, 2015
Endocrine ophthalmopathy is a chronic autoimmune disease of the orbit which can cause loss of vision. It is a multidisciplinary problem involving specialists from different areas.

doaj   +1 more source

Issue Information

open access: yesEye &ENT Research, Volume 3, Issue 1, Page 1-4, March 2026.
No abstract is available for this article.
wiley   +1 more source

Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment

open access: yes, 2008
Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, School of Medicine, Sapporo, JapanPurpose: To investigate whether serum levels of soluble Fas (sFas) and interleukin-6 (IL-6) could ...
Masato Hashimoto   +3 more
core  

Evaluation of Galectin-3 in Graves’ Disease With and Without Ophthalmopathy

open access: yesEndocrinology Research and Practice, 2023
Objective: There is a link between thyroid-associated ophthalmopathy and Graves’ disease; however, the exact pathophysiological mechanism remains unclear.
Muhammed Akın   +4 more
doaj  

Epidemiology and prevention of Graves' ophthalmopathy

open access: yes, 2002
Graves' ophthalmopathy is clinically relevant in approximately 50% of patients with Graves' disease, severe forms affecting 3%-5% of patients. Two age peaks of incidence are observed in the fifth and seventh decades of life, with slight differences ...
Wiersinga, Wilmar M.   +2 more
core   +1 more source

THYROID ASSOCIATED OPHTHALMOPATHY – A REVIEW [PDF]

open access: yes, 2009
Thyroid associated ophthalmopathy is an autoimmune disorder affecting the orbital and periorbital tissues. Hyperthyroidism is commonly associated with thyroid associated ophthalmopathy, however in 5% to 10% of cases it is euthyroid.
MALLIKA PS   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy